Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Jennifer Doudna

Jennifer Doudna

Is an American biochemist. Investor. Founder of Caribou Biosciences, Intellia Therapeutics and Mammoth Biosciences.

Overview Structured Data Issues Contributors Activity

Is a

Person attributes

Founder of

Mammoth Biosciences

Mammoth Diagnostics

Scribe Therapeutics

Editas Medicine

Caribou Biosciences

Intellia Therapeutics

Birthdate

February 19, 1964

Birthplace

Washington, D.C.

Nationality

Author of

A Crack in Creation

0

Location

Educated at

Harvard Medical School

Harvard University

Hilo High School

Awards Received

2020 Wolf Prize in Medicine

2018 Kavli Prize in Nanoscience

2017 Japan Prize

2020 Nobel Prize in Chemistry

2016 Tang Prize in Biopharmaceutical Science

2015 Princess of Asturias Award

2015 Breakthrough Prize in Life Sciences

2014 Jacob Heskel Gabbay Award

...

Occupation

0

0

Invested in

Caribou Biosciences

ORCID

0000-0001-9161-999X0

Open Library ID

OL7396886A0

Academic attributes

Google Scholar ID

Doctoral Thesis Title

Towards the design of an RNA replicase

Doctoral Thesis URL

id.lib.harvard.edu/alma/...atalog

Doctoral Thesis Date

1989

Doctoral Advisor

Jack W. Szostak

Other attributes

Birth Name

Jennifer Anne Doudna

Citizenship

Known for

First X-ray based structure of catalytic RNA

Member of Board of Directors of

Johnson & Johnson

Wikidata ID

\

Timeline

No Timeline data yet.

Current Employer

Patents

Further Resources

Title

Author

Link

Type

Date

References

Find more people like Jennifer Doudna

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.

Open Query Tool

Golden Query Tool